Search This Blog

Saturday, March 16, 2019

Voyager Therapeutics’ Huntington’s Disease treatment granted orphan status

The FDA granted orphan designation to Voyager Therapeutics’ treatment of Huntington’s Disease, according to a post to the agency’s website.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)